What's new

Human medicines European public assessment report (EPAR): RoActemra, tocilizumab, Date of authorisation: 16/01/2009, Revision: 48, Status: Authorised

Human medicines European public assessment report (EPAR): RoActemra, tocilizumab, Date of authorisation: 16/01/2009, Revision: 48, Status: Authorised

May 6, 2025 - 17:09
 0
Human medicines European public assessment report (EPAR): RoActemra, tocilizumab, Date of authorisation: 16/01/2009, Revision: 48, Status: Authorised
Human medicines European public assessment report (EPAR): RoActemra, tocilizumab, Date of authorisation: 16/01/2009, Revision: 48, Status: Authorised
Read More

Tags:

Previous Article

Bluebird pleads for deal support; Unity, Mersana lay off staff

Next Article

Industry research reveals retailers must rethink workforce strategy to weather e...

Related Posts

Human medicines European public assessment report (EPAR): Posaconazole Accord, posaconazole, Date of authorisation: 25/07/2019, Revision: 12, Status: Authorised

Human medicines European public assessment report (EPAR...

May 6, 2025  0

Human medicines European public assessment report (EPAR): mResvia, Single-stranded 5' capped mRNA encoding the Respiratory syncytial virus glycoprotein F stabilized in the prefusion conformation, Date of authorisation: 22/08/2024, Revision: 4, Status: Authorised

Human medicines European public assessment report (EPAR...

May 5, 2025  0

Summary of opinion: Calquence, 25/04/2025 Positive

Summary of opinion: Calquence, 25/04/2025 Positive

Apr 25, 2025  0